Centogene
在场
是其中之一......
Quest Diagnostics 是一家在股票代码 DGX (US) 下上市的公司。
Quest Diagnostics 在 3 个国家有直接业务。Quest Diagnostics 拥有 4家子公司，其中包括 Centogene、Hemostasis Reference Laboratory 和 LifeLabs。
他们在：
涉及Quest Diagnostics的并购和融资。
- Quest Diagnostics 已收购 LifeLabs (公布2024八月26号).
- Quest Diagnostics has announced the acquisition of LifeLabs (公布2024七月5号).
- Quest Diagnostics has announced the acquisition of Haystack Oncology (公布2023五月2号).
高管
查看带有其 14 名主要高管的组织结构图
Centogene 搜索最多的简介
- Kim Stratton, Chief Executive Officer
- Peer Schatz, Chairman of the Supervisory Board
- Mary Sheahan, Member of the Supervisory Board
高管在Quest Diagnostics变化
- Robert Carter已作为Director加入公司 (新闻发布的2024五月19号).
- Murali Balakumar已作为Senior Vice President and Chief Information & Digital Officer加入公司 (新闻发布的2024五月7号).
创建提醒
跟踪 Centogene 的高管变动
生物技术
Quest Diagnostics 拥有 2,332 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- March Biosciences 刚刚宣布为 28 筹款数百万美元。 (公布2024十二月3号).
- Lyell Immunopharma 已收购 ImmPACT Bio (公布2024十一月29号).
- Hopo Therapeutics 刚刚宣布为 226 筹款数百万美元。 (公布2024十一月29号).
生物技术 行业的其他推荐联系人
消息
Centogene 的最新新闻稿
- CENTOGENE Signs Strategic Transaction With Private Equity Group Charme Capital Partners
- CENTOGENE Receives Delisting Notice From Nasdaq
- CENTOGENE Publication in Brain Journal Reveals 15% of Parkinson’s Disease Cases Are Linked to Genetic Factors
- C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development
- CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting
- CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position
- CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
- CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights
- CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients
- News: Get the latest information, publications and news: centogene.com
- View more press releases Close
关于 Centogene 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Kim Stratton 
